Answers are grounded in this paper and cite their sources.
PSEN1 variants are the most common cause of familial early-onset Alzheimer's disease (EOAD), but it is debated whether they act through a loss- or gain-of-function. Following a recent report of a duo with EOAD carrying a predicted loss-of-function (LoF) stop-gain variant (p.K109*) in PSEN1 , we sought to determine whether PSEN1 LoF variants, as a class, cause EOAD. We identified 45 carriers of PSEN1 LoF variants predicted to trigger nonsense-mediated decay in the Alzheimer's Disease Sequencing Project, UK Biobank, and BioVU databases. None of these carriers had a recorded case of early-onset dementia, and 17 were older than 65 years at last follow-up with no dementia or AD reported. Re-analysis of the reported AD-associated variant p.K109* revealed a cryptic splice site predicted to produce an in-frame deletion of 5 amino acids (p.K109_L113del). These results suggest that PSEN1 variants must produce an altered PSEN1 protein product to cause EOAD, while true null LoF PSEN1 alleles do not cause EOAD.
No takes yet. Share an insight, caveat, or question.
Farinas et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: